Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-17

Clinical Trial Update: A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing HC-SVT-1001 and HC-SVT-1002 for surgical treatment of atrophic pseudarthrosis of long bones (Bonecure) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HC-SVT-1001
  • HC-SVT-1002

Snippet

Sponsor: Salvat | Conditions: Pseudoarthrosis | Phase 2 | Status: COMPLETED